Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:tralokinumab
|
| gptkbp:approvalYear |
2021
|
| gptkbp:approvedBy |
gptkb:European_Union
gptkb:United_States |
| gptkbp:ATCCode |
D11AH07
|
| gptkbp:form |
solution for injection
pre-filled syringe |
| https://www.w3.org/2000/01/rdf-schema#label |
Adtralza
|
| gptkbp:indication |
gptkb:atopic_dermatitis
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketingAuthorizationHolder |
gptkb:LEO_Pharma
|
| gptkbp:mechanismOfAction |
IL-13 inhibitor
|
| gptkbp:pregnancyCategory |
not assigned
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
conjunctivitis
injection site reactions upper respiratory tract infections |
| gptkbp:target |
gptkb:interleukin-13
|
| gptkbp:bfsParent |
gptkb:LEO_Pharma
|
| gptkbp:bfsLayer |
7
|